Recombinant insulin glargine (Gan & Lee)

重组甘精胰岛素（甘李药业）

Report date: 2026/04/29 20:02:18

Base Information

Drug NameRecombinant insulin glargine (Gan & Lee)
Drug Alias NameInsulin glargine biosimilarBasal insulin glargine长秀霖BasalinGL-GLA
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonistsOrnithine decarboxylase stimulantsPhosphokinases stimulants
TargetsInsulin receptorOrnithine decarboxylasePhosphokinases
Therapy Area/IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2005/05/10
Country/TerritoryUnited StatesGermanyEgypt +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGan & Lee Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesGan & Lee Pharmaceuticals
Inactive CompaniesGan And Lee Pharmaceuticals, Usa
Active IndicationsDiabetes Mellitus
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeA10AE04
Related LinksN/A